Additionally, we showed that LentiCRISPR/SaCas9-mediated disruption of CCR5 was effective in CD34+ HSPCs, and whether engraftment of CCR5-edited CD34+ HSPCs into humanized mouse resistance to HIV-1 infection requires further exploration. The gene discussed is CCR5; the disease is HIV-1 infection.